Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA055261-06
Application #
6269517
Study Section
Project Start
1998-02-01
Project End
1999-01-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Liu, Yanhong; Shete, Sanjay; Hosking, Fay et al. (2010) Genetic advances in glioma: susceptibility genes and networks. Curr Opin Genet Dev 20:239-44
Puduvalli, V K; Sampath, D; Bruner, J M et al. (2005) TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation. Apoptosis 10:233-43
Levin, Victor A; Hess, Kenneth R; Choucair, Ali et al. (2003) Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Clin Cancer Res 9:981-90
Puduvalli, Vinay K; Hashmi, Masood; McAllister, Leslie D et al. (2003) Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival. Oncology 65:259-66
Wrensch, Margaret; Minn, Yuriko; Chew, Terri et al. (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278-99
Berrak, Su Gulsun; Ozek, Memet M; Canpolat, Cengiz et al. (2002) Association between DNA content and tumor suppressor gene expression and aggressiveness of atypical teratoid/rhabdoid tumors. Childs Nerv Syst 18:485-91
de Andrade, M; Barnholtz, J S; Amos, C I et al. (2001) Segregation analysis of cancer in families of glioma patients. Genet Epidemiol 20:258-70
Steck, P A; Lin, H; Langford, L A et al. (1999) Functional and molecular analyses of 10q deletions in human gliomas. Genes Chromosomes Cancer 24:135-43
Groves, M D; Maor, M H; Meyers, C et al. (1999) A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 45:127-35
Hess, K R (1999) Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 42:227-31

Showing the most recent 10 out of 36 publications